发明名称 BENZOQUINAZOLINE COMPOUNDS
摘要 Compounds of formula (I) or salts thereon; wherein the dotted line represent s a single or double bond, R1 is alkyl or ami- no optionally substituted by alkyl, alkanoyl or benzyl group; R2, R3, R4 and R5 are the same or different and each is select- ed from hydrogen, phenyl, halo, nitro, a group S(O)n R8 wherein n is the integer 0, 1 or 2 and R8 is halo or alkyl or a group NR9R10 wherein R9 and R10 are both hydrogen, a group NR11R12 wherein R11 and R12 are the same or different and each is hydrogen or alkyl, a group OR13 wherein R13 is hydrogen or C1-4 of alkyl optionally substituted by halo; a C1-4 aliphatic group optionally substituted by a group OR14 or NR14R15 wherein R14 and R15 are the same or different and each is hydrog- en or alkyl; or two of R2 to R5 are linked together to form a benzo group; o r one of R2 to R5 is a group X-Y-R16 wherein X is CH2, NR17, CO or S(O)m and Y is CH2, NR17, O or S(O)m, or X-Y is O, NR17, -C H= CH- or N=N-; are disclosed as phar- macological agents useful in the treatment of tumours. Pharmaceutical compositions and methods for the preparation of compounds of formula (I) are also described.
申请公布号 CA2085589(C) 申请公布日期 2001.12.18
申请号 CA19912085589 申请日期 1991.06.18
申请人 THE WELLCOME FOUNDATION LIMITED 发明人 PENDERGAST, WILLIAM;DICKERSON, SCOTT H.;JOHNSON, JULIUS V.;FERONE, ROBERT
分类号 A61K31/505;A61K31/00;A61K31/50;A61K31/501;A61K31/517;A61P31/00;A61P31/04;A61P35/00;A61P35/02;C07D;C07D239/70;C07D239/88;C07D239/90;C07D239/95;C07D403/12;C07D417/12;(IPC1-7):C07D239/70;A61K38/04;C07K5/04;C07D409/12;C07D413/12 主分类号 A61K31/505
代理机构 代理人
主权项
地址